{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,12]],"date-time":"2025-10-12T20:04:09Z","timestamp":1760299449266},"reference-count":39,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2016,10,22]],"date-time":"2016-10-22T00:00:00Z","timestamp":1477094400000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clin Oral Invest"],"published-print":{"date-parts":[[2017,6]]},"DOI":"10.1007\/s00784-016-1975-0","type":"journal-article","created":{"date-parts":[[2016,10,22]],"date-time":"2016-10-22T03:21:46Z","timestamp":1477106506000},"page":"1895-1903","update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["Immunoexpression of IGF1, IGF2, and osteopontin in craniofacial bone repair associated with autogenous grafting in rat models treated with alendronate sodium"],"prefix":"10.1007","volume":"21","author":[{"given":"Paulo Roberto","family":"Camati","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Allan Fernando","family":"Giovanini","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hugo Eduardo","family":"de Miranda Peixoto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cassiana Majewski","family":"Schuanka","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maria Cec\u00edlia","family":"Giacomel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Melissa Rodrigues","family":"de Ara\u00fajo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jo\u00e3o C\u00e9sar","family":"Zielak","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rafaela","family":"Scariot","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tatiana Miranda","family":"Deliberador","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2016,10,22]]},"reference":[{"key":"1975_CR1","doi-asserted-by":"crossref","first-page":"2347","DOI":"10.1016\/S0142-9612(00)00102-2","volume":"21","author":"KJ Burg","year":"2000","unstructured":"Burg KJ, Porter S, Kellam JF (2000) Biomaterial developments for bone tissue engineering. Biomaterials 21:2347\u20132359","journal-title":"Biomaterials"},{"key":"1975_CR2","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1258\/la.2010.010085","volume":"45","author":"PS Gomes","year":"2011","unstructured":"Gomes PS, Fernandes MH (2011) Rodent models in bone-related research: the relevance of calvarial defects in the assessment of bone regeneration strategies. Lab Animals 45:14\u201324","journal-title":"Lab Animals"},{"key":"1975_CR3","volume-title":"Physicians\u2019 desk reference","author":"PDR Thompson","year":"2003","unstructured":"Thompson PDR (2003) Physicians\u2019 desk reference, 57th edn. Medical Economics, Montvale, NJ","edition":"57"},{"key":"1975_CR4","doi-asserted-by":"crossref","first-page":"5356","DOI":"10.1200\/JCO.2009.21.9584","volume":"27","author":"K Vahtsevanos","year":"2009","unstructured":"Vahtsevanos K et al (2009) Longitudinal cohort study of risk factors in cancer patients of bisphosphonate-related osteonecrosis of the jaw. J Clin Oncol 27:5356","journal-title":"J Clin Oncol"},{"key":"1975_CR5","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1016\/j.ygyno.2008.11.029","volume":"112","author":"T Fehm","year":"2009","unstructured":"Fehm T, Beck V, Banys M et al (2009) Bisphosphonate-induced osteonecrosis of the jaw (ONJ): incidence and risk factors in patients with breast cancer and gynecological malignancies. Gynecol Oncol 112:605","journal-title":"Gynecol Oncol"},{"key":"1975_CR6","doi-asserted-by":"crossref","first-page":"1341","DOI":"10.1093\/annonc\/mdr435","volume":"23","author":"F Saad","year":"2012","unstructured":"Saad F, Brown JE, Van Poznak C et al (2012) Incidence, risk factors, and outcomes of osteonecrosis of the jaw: integrated analysis from three blinded active-controlled phase III trials in cancer patients with bone metastases. Ann Oncol 23:1341","journal-title":"Ann Oncol"},{"key":"1975_CR7","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1007\/s00784-009-0294-0","volume":"14","author":"J Rustemeyer","year":"2010","unstructured":"Rustemeyer J, Bremerich A (2010) Bisphosphonate-associated osteonecrosis of the jaw: what do we currently know? A survey of knowledge given in the recent literature. Clin Oral Invest 14:59\u201364","journal-title":"Clin Oral Invest"},{"key":"1975_CR8","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1007\/s00784-012-0708-2","volume":"17","author":"C Jacobsen","year":"2013","unstructured":"Jacobsen C, Metzler P, R\u00f6ssle M, Obwegeser J, Zemann W, Gr\u00e4tz KW (2013) Osteopathology induced by bisphosphonates and dental implants: clinical observations. Clin Oral Invest 17:167\u2013175","journal-title":"Clin Oral Invest"},{"key":"1975_CR9","doi-asserted-by":"crossref","unstructured":"Toker H, Ozdemir H, Ozer H, Eren K (2012) Alendronate enhances osseous healing in a rat calvarial defect model. Elsevier 57:1545\u20131550.","DOI":"10.1016\/j.archoralbio.2012.06.013"},{"key":"1975_CR10","doi-asserted-by":"crossref","first-page":"2237","DOI":"10.1359\/jbmr.2002.17.12.2237","volume":"17","author":"Y Cao","year":"2002","unstructured":"Cao Y, Mori S, Mashiba T, Westmore MS, Ma L, Sato M, Akiyama T, Shi L, Komatsubara S, Miyamoto K et al (2002) Raloxifene, estrogen, and alendronate affect the processes of fracture repair differently in ovariectomized rats. J Bone Miner Res 17:2237\u20132246","journal-title":"J Bone Miner Res"},{"key":"1975_CR11","first-page":"3109","volume":"85","author":"RP Tonino","year":"2000","unstructured":"Tonino RP et al (2000) Skeletal benefits of alendronate: 7-year treatment of postmenopausal osteoporotic women. Phase III Osteoporosis Treatment Study Group. J Clin Endocrinol Metab 85:3109\u20133115","journal-title":"J Clin Endocrinol Metab"},{"key":"1975_CR12","doi-asserted-by":"crossref","first-page":"1189","DOI":"10.1056\/NEJMoa030897","volume":"350","author":"HG Bone","year":"2004","unstructured":"Bone HG et al (2004) Ten years\u2019 experience with alendronate for osteoporosis in postmenopausal women. N Engl J Med 350:1189\u20131199","journal-title":"N Engl J Med"},{"key":"1975_CR13","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1111\/j.1601-0825.2011.01829.x","volume":"17","author":"JH Kim","year":"2011","unstructured":"Kim JH, Park YB, Li Z, Shim JS, Moon HS, Jung HS, Chung MK (2011) Effect of alendronate on healing of extraction sockets and healing around implants. Oral Dis 17:705\u2013711","journal-title":"Oral Dis"},{"key":"1975_CR14","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1046\/j.1537-2995.1990.30891020337.x","volume":"30","author":"JW Gibble","year":"1990","unstructured":"Gibble JW, Ness PM (1990) Fibrin glue: the perfect operative sealant? Transfusion 30:741\u2013747","journal-title":"Transfusion"},{"key":"1975_CR15","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1016\/S0901-5027(05)80176-6","volume":"20","author":"G Hotz","year":"1991","unstructured":"Hotz G (1991) Alveolar ridge augmentation with hydroxylapatite using fibrin sealant for fixation. Part II: clinical application. Int J Oral Maxillofac Surg 20:208\u2013213","journal-title":"Int J Oral Maxillofac Surg"},{"key":"1975_CR16","doi-asserted-by":"crossref","first-page":"1481","DOI":"10.1359\/jbmr.090226","volume":"24","author":"S Yakar","year":"2009","unstructured":"Yakar S et al (2009) Serum IGF-1 determines skeletal strength by regulating subperiosteal expansion and trait interactions. J Bone Miner Res 24:1481\u20131492","journal-title":"J Bone Miner Res"},{"key":"1975_CR17","doi-asserted-by":"crossref","unstructured":"Mohan S, Baylink DJ (1991) Bone growth factors. Clin Orthop Relat Res 30\u201348.","DOI":"10.1097\/00003086-199102000-00004"},{"key":"1975_CR18","doi-asserted-by":"crossref","first-page":"277","DOI":"10.3109\/03008208909023897","volume":"20","author":"TL McCarthy","year":"1989","unstructured":"McCarthy TL, Centrella M, Canalis E (1989) Insulin-like growth factor (IGF) and bone. Connect Tissue Res 20:277\u2013282","journal-title":"Connect Tissue Res"},{"key":"1975_CR19","doi-asserted-by":"crossref","first-page":"900","DOI":"10.1172\/JCI118137","volume":"96","author":"SK Grinspoon","year":"1995","unstructured":"Grinspoon SK, Baum HB, Peterson S et al (1995) Effects of rhIGF- I administration on bone turnover during short-term fasting. J Clin Invest 96:900\u2013906","journal-title":"J Clin Invest"},{"key":"1975_CR20","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1210\/en.2002-220948","volume":"144","author":"S Mohan","year":"2003","unstructured":"Mohan S, Richman C, Guo R et al (2003) Insulin-like growth factor regulates peak bone mineral density in mice by both growth hormone-dependent and -independent mechanisms. Endocrinology 144:929\u2013936","journal-title":"Endocrinology"},{"issue":"15","key":"1975_CR21","doi-asserted-by":"crossref","first-page":"8352","DOI":"10.1073\/pnas.140021997","volume":"97","author":"GR Beck Jr","year":"2000","unstructured":"Beck GR Jr, Zerler B, Moran E (2000) Phosphate is a specific signal for induction of osteopontin gene expression. Proc Natl Acad Sci U S A 97(15):8352\u20138357","journal-title":"Proc Natl Acad Sci U S A"},{"key":"1975_CR22","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1111\/j.1365-2184.1998.tb01196.x","volume":"31","author":"W Engstr\u00f6m","year":"1998","unstructured":"Engstr\u00f6m W, Shokrai A, Otte K, Gran\u00e9rus M, Gessbo A, Bierke P, Madej A, Sj\u00f6lund M, Ward A (1998) Transcriptional regulation and biological significance of the insulin like growth factor II gene. Cell Prolif 31:173\u2013189","journal-title":"Cell Prolif"},{"issue":"8","key":"1975_CR23","doi-asserted-by":"crossref","first-page":"3295","DOI":"10.1210\/endo.137.8.8754754","volume":"137","author":"CA Conover","year":"1996","unstructured":"Conover CA, Lee PD, Riggs BL, Powell DR (1996) Insulin-like growth factor-binding protein-1 expression in cultured human bone cells: regulation by insulin and glucocorticoid. Endocrinology 137(8):3295\u20133301","journal-title":"Endocrinology"},{"key":"1975_CR24","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/j.peptides.2013.09.006","volume":"49","author":"S Aydin","year":"2013","unstructured":"Aydin S, Celik O, Gurates B, Sahin I, Ulas M, Yilmaz M, Kalayci M, Kuloglu T, Catak Z, Aksoy A, Ozercan IH, Kumru S (2013) Concentrations of preptin, salusins and hepcidins in plasma and milk of lactating women with or without gestational diabetes mellitus. Peptides 49:123\u2013130","journal-title":"Peptides"},{"issue":"8","key":"1975_CR25","first-page":"BR293","volume":"8","author":"S Xie","year":"2002","unstructured":"Xie S, Kang JX (2002) Differential expression of the mannose 6-phosphate\/insulin-like growth factor-II receptor in human breast cancer cell lines of different invasive potential. Med Sci Monit 8(8):BR293\u2013BR300","journal-title":"Med Sci Monit"},{"key":"1975_CR26","first-page":"10","volume":"30","author":"KH Lau","year":"2015","unstructured":"Lau KH, Baylink DJ, Sheng MH (2015) Osteocyte-derived insulin-like growth factor I is not essential for the bone repletion response in mice. PLoS One Jan 30:10","journal-title":"PLoS One Jan"},{"key":"1975_CR27","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1016\/j.tripleo.2007.06.010","volume":"105","author":"G Giro","year":"2008","unstructured":"Giro G, Gon\u00e7alves D, Sakakura CE, Pereira RMR, Marcantonio EJ, Orrico SRP (2008) Oral Surg Oral Med Oral Pathol Oral Radiol Endod 105:162\u2013167","journal-title":"Oral Surg Oral Med Oral Pathol Oral Radiol Endod"},{"key":"1975_CR28","doi-asserted-by":"crossref","first-page":"1901","DOI":"10.1902\/jop.2005.76.11.1901","volume":"76","author":"AM Menezes","year":"2005","unstructured":"Menezes AM, Rocha FA, Chaves HV, Carvalho CB, Ribeiro RA, Brito GA (2005) Effect of sodium alendronate on alveolar bone resorption in experimental periodontitis in rats. J Periodontol 76:1901\u20131909","journal-title":"J Periodontol"},{"key":"1975_CR29","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1038\/bonekey.2013.171","volume":"2","author":"AR Guntur","year":"2013","unstructured":"Guntur AR, Rosen CJ (2013) IGF-1 regulation of key signaling pathways in bone. Bonekey Rep 2:437","journal-title":"Bonekey Rep"},{"issue":"4","key":"1975_CR30","doi-asserted-by":"crossref","first-page":"C1220","DOI":"10.1152\/ajpcell.2000.279.4.C1220","volume":"279","author":"SV Komarova","year":"2000","unstructured":"Komarova SV, Ataullakhanov FI, Globus RK (2000) Bioenergetics and mitochondrial transmembrane potential during differentiation of cultured osteoblasts. Am J Physiol Cell Physiol 279(4):C1220\u2013C1229","journal-title":"Am J Physiol Cell Physiol"},{"issue":"2","key":"1975_CR31","doi-asserted-by":"crossref","first-page":"122","DOI":"10.5483\/BMBRep.2016.49.2.228","volume":"49","author":"L Chen","year":"2016","unstructured":"Chen L, Zou X, Zhang RX, Pi CJ, Wu N, Yin LJ, Deng ZL (2016) IGF1 potentiates BMP9-induced osteogenic differentiation in mesenchymal stem cells through the enhancement of BMP\/Smad signaling. BMB Rep 49(2):122\u2013127","journal-title":"BMB Rep"},{"issue":"1","key":"1975_CR32","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1073\/pnas.96.1.133","volume":"96","author":"JE Fisher","year":"1999","unstructured":"Fisher JE, Rogers MJ, Halasy JM, Luckman SP, Hughes DE, Masarachia PJ, Wesolowski G, Russell RG, Rodan GA, Reszka AA (1999) Alendronate mechanism of action: geranylgeraniol, an intermediate in the mevalonate pathway, prevents inhibition of osteoclast formation, bone resorption, and kinase activation in vitro. Proc Natl Acad Sci U S A 96(1):133\u2013138","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"3 Pt 2","key":"1975_CR33","first-page":"R696","volume":"271","author":"K Reiser","year":"1996","unstructured":"Reiser K, Summers P, Medrano JF, Rucker R, Last J, McDonald R (1996) Effects of elevated circulating IGF-1 on the extracellular matrix in \u201chigh-growth\u201d C57BL\/6J mice. Am J Phys 271(3 Pt 2):R696\u2013R703","journal-title":"Am J Phys"},{"issue":"26","key":"1975_CR34","doi-asserted-by":"crossref","first-page":"16440","DOI":"10.1074\/jbc.M115.641670","volume":"290","author":"A Herchenhan","year":"2015","unstructured":"Herchenhan A, Uhlenbrock F, Eliasson P, Weis M, Eyre D, Kadler KE, Magnusson SP, Kjaer M (2015) Lysyl oxidase activity is required for ordered collagen fibrillogenesis by tendon cells. J Biol Chem 290(26):16440\u201316450","journal-title":"J Biol Chem"},{"issue":"6","key":"1975_CR35","doi-asserted-by":"crossref","first-page":"1597","DOI":"10.1016\/j.bone.2010.02.026","volume":"46","author":"AF Giovanini","year":"2010","unstructured":"Giovanini AF, Deliberador TM, Gonzaga CC, de Oliveira Filho MA, G\u00f6hringer I, Kuczera J, Zielak JC, de Andrade Urban C (2010) Platelet-rich plasma diminishes calvarial bone repair associated with alterations in collagen matrix composition and elevated CD34+ cell prevalence. Bone 46(6):1597\u20131603","journal-title":"Bone"},{"issue":"6892","key":"1975_CR36","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1038\/nature00819","volume":"417","author":"M Constancia","year":"2002","unstructured":"Constancia M, Hemberger M, Hughes J, Dean W, Ferguson-Smith A, Fundele R et al (2002) Placental-specific IGF-II is a major modulator of placental and fetal growth. Nature 417(6892):945\u2013948","journal-title":"Nature"},{"issue":"2","key":"1975_CR37","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/j.cytogfr.2008.01.005","volume":"19","author":"W Chao","year":"2008","unstructured":"Chao W, D\u2019Amore PA (2008) IGF2: epigenetic regulation and role in development and disease. Cytokine Growth Factor Rev 19(2):111\u2013120","journal-title":"Cytokine Growth Factor Rev"},{"issue":"5","key":"1975_CR38","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1083\/jcb.200307158","volume":"163","author":"E Erbay","year":"2003","unstructured":"Erbay E, Park IH, Nuzzi PD, Schoenherr CJ, Chen J (2003) IGF-II transcription in skeletal myogenesis is controlled by mTOR and nutrients. J Cell Biol 163(5):931\u2013936","journal-title":"J Cell Biol"},{"issue":"3","key":"1975_CR39","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1096\/fj.03-0699com","volume":"18","author":"GR Grotendorst","year":"2004","unstructured":"Grotendorst GR, Rahmanie H, Duncan MR (2004) Combinatorial signaling pathways determine fibroblast proliferation and myofibroblast differentiation. FASEB J 18(3):469\u2013479","journal-title":"FASEB J"}],"container-title":["Clinical Oral Investigations"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00784-016-1975-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00784-016-1975-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00784-016-1975-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,9,14]],"date-time":"2019-09-14T18:52:03Z","timestamp":1568487123000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00784-016-1975-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,10,22]]},"references-count":39,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2017,6]]}},"alternative-id":["1975"],"URL":"https:\/\/doi.org\/10.1007\/s00784-016-1975-0","relation":{},"ISSN":["1432-6981","1436-3771"],"issn-type":[{"value":"1432-6981","type":"print"},{"value":"1436-3771","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,10,22]]}}}